Battista, T.; Pascarella, G.; Staid, D.S.; Colotti, G.; Rosati, J.; Fiorillo, A.; Casamassa, A.; Vescovi, A.L.; Giabbai, B.; Semrau, M.S.;
et al. Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. Int. J. Mol. Sci. 2021, 22, 1293.
https://doi.org/10.3390/ijms22031293
AMA Style
Battista T, Pascarella G, Staid DS, Colotti G, Rosati J, Fiorillo A, Casamassa A, Vescovi AL, Giabbai B, Semrau MS,
et al. Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. International Journal of Molecular Sciences. 2021; 22(3):1293.
https://doi.org/10.3390/ijms22031293
Chicago/Turabian Style
Battista, Theo, Gianmarco Pascarella, David Sasah Staid, Gianni Colotti, Jessica Rosati, Annarita Fiorillo, Alessia Casamassa, Angelo Luigi Vescovi, Barbara Giabbai, Marta Stefania Semrau,
and et al. 2021. "Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells" International Journal of Molecular Sciences 22, no. 3: 1293.
https://doi.org/10.3390/ijms22031293
APA Style
Battista, T., Pascarella, G., Staid, D. S., Colotti, G., Rosati, J., Fiorillo, A., Casamassa, A., Vescovi, A. L., Giabbai, B., Semrau, M. S., Fanelli, S., Storici, P., Squitieri, F., Morea, V., & Ilari, A.
(2021). Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. International Journal of Molecular Sciences, 22(3), 1293.
https://doi.org/10.3390/ijms22031293
